Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.
about
Targeting inflammation in pancreatic cancer: Clinical translationTumor-Associated Macrophages and Neutrophils in Tumor MicroenvironmentIon channels and transporters in tumour cell migration and invasionHarnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesisGenetically engineered mouse models of pancreatic adenocarcinomaRegulation of pancreatic function by connective tissue growth factor (CTGF, CCN2)Tumor stroma as targets for cancer therapyCXCR2: a target for pancreatic cancer treatment?Human correlates of provocative questions in pancreatic pathologyExploiting inflammation for therapeutic gain in pancreatic cancerMet receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancerNeutrophils and Granulocytic MDSC: The Janus God of Cancer ImmunotherapyImmune checkpoint and inflammation as therapeutic targets in pancreatic carcinomaTargeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implicationsAttenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesisAsporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast CancerCXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.The roles of TGFβ in the tumour microenvironment.Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple OpponentsClinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma.Pancreatic biomarkers: could they be the answer?Platelets guide the formation of early metastatic niches.Pancreatic cancer and its stroma: a conspiracy theoryVitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.Control of CXCR2 activity through its ubiquitination on K327 residue.Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-β signaling.TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactionsMacrophage polarization in pancreatic carcinoma: role of heparanase enzyme.Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironmentDisruption of STAT3 signalling promotes KRAS-induced lung tumorigenesisOverexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival.Role of IL-6 in the resolution of pancreatitis in obese miceCXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis.PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop.A CXCL1 paracrine network links cancer chemoresistance and metastasis
P2860
Q26751686-16E6B21A-D74C-40AB-9161-2B11FF0D50A7Q26766429-9E62AD3A-77FF-484D-9594-A22774E2B94BQ26849490-A4C5C800-3241-4746-AD06-2361B728E365Q26861766-1A5E8670-5DD8-4B3E-A05D-2C7DB7CEDD05Q27002973-7023656F-F577-4B06-BED0-577F2C8DC57DQ27012580-8900422A-3B8C-418C-B5FD-4CFB02F79215Q27015980-CF5577C4-C1C5-4FE8-B881-6A5404A14B1EQ27021588-8D9BAE70-9522-4F89-BFCF-293D91D2327CQ27023576-D2714DEA-42F7-4883-9C37-F622EE7E1709Q27027661-76C28E6E-802E-4894-936A-591ABC1B3F51Q27334957-A23DCF53-FC72-4CB6-BC3F-C6BA76437036Q28069360-881647CD-E48C-4598-94E6-C52F52C1C842Q28069864-069C2804-F35A-477D-8B2B-448E961D6FAFQ28269990-5F5B9596-2FFD-404E-A9B6-144D3548A472Q28386225-779499E4-ED4C-4CE1-B4A2-C95B44841CB4Q28547683-698E54C6-12B8-4549-90C9-16B842F58E78Q30358993-B968D980-E85F-46D5-9819-1858267220E2Q30754497-452936EF-E002-4508-B197-AA033EBE408DQ30829535-9256CA06-8130-452A-8B27-207E0C2A2360Q33630845-B6644021-B3E3-4527-93F7-E4C0F6B80C52Q33704284-F3DD9F95-6387-462F-8F40-0056C23388FBQ33757722-E0650E29-B7F2-4472-954E-38077538220CQ33801371-47F2F24C-872F-4AC7-A796-FA68AB061BCEQ34002250-B81C3BD4-56FB-4A63-B7C9-EB39DA260E17Q34093809-33A5CF3C-3D11-466D-A64B-FE8154F40254Q34253198-4EEE96CC-8661-469E-9D18-303D4B9BE3D9Q34404577-3AC46D39-5D91-4AF9-9E10-460D41EF57D6Q34585721-06B1C22D-7FE4-4647-A23F-F11DF0FF285DQ35023562-B7F87026-8206-4CC8-AD57-34325EC88D5EQ35102577-5D592564-1DB8-4B4E-A24D-CDE4256746F5Q35131817-498BCB58-BE19-4005-81F7-B8DAF5882FC8Q35148340-FC6FE667-CD61-410A-94EE-45E46AEC1674Q35196919-4E8CB4D6-924C-4A53-BA89-01B342AA2CA2Q35223880-38E4F814-8610-4F42-881A-AA570E3BD6F2Q35988584-943B3E54-5C0B-4E83-9EAB-5020E2BF4521Q36041701-034353C2-F36A-4D76-BE14-3854FCC54A7DQ36188900-04F14562-6E96-4C56-805F-81E3B163DA36Q36190681-4717037F-526E-46CF-81B3-8F37BD3CD7A8Q36355925-7D7F767D-9996-428F-B6AB-B80D7773B5E1Q36482032-020FB229-1E34-4037-BB08-3804B95CC631
P2860
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inhibiting Cxcr2 disrupts tumo ...... creatic ductal adenocarcinoma.
@ast
Inhibiting Cxcr2 disrupts tumo ...... creatic ductal adenocarcinoma.
@en
type
label
Inhibiting Cxcr2 disrupts tumo ...... creatic ductal adenocarcinoma.
@ast
Inhibiting Cxcr2 disrupts tumo ...... creatic ductal adenocarcinoma.
@en
prefLabel
Inhibiting Cxcr2 disrupts tumo ...... creatic ductal adenocarcinoma.
@ast
Inhibiting Cxcr2 disrupts tumo ...... creatic ductal adenocarcinoma.
@en
P2093
P2860
P50
P356
P1476
Inhibiting Cxcr2 disrupts tumo ...... creatic ductal adenocarcinoma.
@en
P2093
Agnieszka E Gorska
Anna Chytil
Christopher V E Wright
Hideaki Ijichi
Keisuke Tateishi
Koji Miyabayashi
Mary E Aakre
Masao Omata
Motohisa Tada
P2860
P304
P356
10.1172/JCI42754
P407
P577
2011-09-19T00:00:00Z